Entrepreneur UK's London 100: All Things Butter
All Things Butter is a rapidly growing London startup disrupting the unassuming dairy scene
Opinions expressed by Entrepreneur contributors are their own.
You're reading Entrepreneur United Kingdom, an international franchise of Entrepreneur Media.
Industry: Food and Beverage
Co-founded by childhood friends Toby Hopkinson and chef Thomas Straker, All Things Butter is a rapidly growing London startup disrupting the unassuming dairy scene.
After securing £2.2m in seed funding, they sold 750k+ blocks of butter in 2024 — enough to scale Mount Everest 7.5 times!
Born from a viral wild garlic butter recipe that hit 4 million views on Instagram, All Things Butter has turned a simple ingredient into a foodie craze.
Their flavored butters — including the first-ever Cinnamon Bun and Chocolate varieties — have taken the market by storm.
In just 10 weeks, they sold over 100,000 blocks.
Dominating the £1.6m butter category, they support British farming, donating 1% of profits to RABI.
Proudly British, they partner with one of England's oldest dairy farms, supporting farmers they know by name.
All Things Butter is making butter cool again!
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Herspiegel Acquires Decisive Consulting to Expand Global Life Sciences Commercialization Services
Blending Bold Strategy with Proven Market Access and Health Economics Expertise to Unlock Asset Value YARDLEY, Pa. and LONDON, June 23, 2025 /PRNewswire/ -- Herspiegel, a leader in pharmaceutical commercialization services, today announced the acquisition of Decisive Consulting. This strategic expansion unites Decisive's global market access focused "Rebel Thinking" with Herspiegel's world-class commercialization services, creating a powerhouse of strategy, evidence, and execution across the product lifecycle. Known for its bold, creative problem-solving, Decisive Consulting helps life sciences companies challenge convention to drive breakthrough market access. Now united with the recently acquired FIECON's industry-leading HEOR and HTA expertise and Herspiegel's proven U.S. market access and commercialization capabilities, the combined set of commercialization services helps clients navigate complexity and seize opportunity from early asset strategy to launch readiness and market optimization. This integrated approach brings together scientific insight, evidence strategy, deep market intuition, and executional precision to ensure brands are built to lead. "The addition of Decisive Consulting further strengthens our ability to unlock asset value and improve patient access to life-changing therapies. Together, we offer the full spectrum of global market access expertise—from early evidence planning through successful launch and beyond." Brent Herspiegel, CEO of Herspiegel Esther Nzenza, CEO and Founder of Decisive Consulting, will remain with Herspiegel as Senior Partner Global Value and Market Access. Esther will continue in a leadership role to deliver industry-leading strategy and impact for clients seeking to expand access to their innovative treatments across international markets. "As part of Herspiegel we will be a true powerhouse in Access, HEOR and go to market strategy, scaled and able to cover worldwide markets with fluency and with industry leading capabilities across the areas that we serve." Esther Nzenza, Founder of Decisive Consulting Together with the recent integration of FIECON, Herspiegel and Decisive Consulting will power commercial success to enable access to innovative medicines and improve patient outcomes worldwide. Learn more at Media Contact: Sue FeeMarketing DirectorPhone: 610-290-3473 1020 Stony Hill Rd, Suite 200, Yardley, PA 19067 About Herspiegel Herspiegel is a leading commercialization consulting firm that helps life science clients maximize their brand potential. With expertise spanning market access, medical affairs, marketing, and patient services, Herspiegel has supported over 150 pharmaceutical product launches across oncology, rare disease, biosimilars, and general medicine brands. Our team of MDs, PhDs, MBAs, and pharmacists deliver strategic insights and operational excellence to ensure commercial success. About Decisive Consulting Decisive Consulting, founded in 2020 to challenge assumptions around value, evidence, and access strategy. We are challenge agents and change enablers, we enjoy the "difficult" and the opportunity to bring the "what if" to a robust and well-argued debate. We believe there needs to be more creativity in access strategy to challenge the status quo and realize what's possible. Our Rebel Thinking leads to breakthrough access results, even in challenging circumstances. Decisive has supported more than 45 companies since inception from early-stage portfolio design through to HTA strategy and execution across multiple countries. View original content to download multimedia: SOURCE Herspiegel Consulting
Yahoo
42 minutes ago
- Yahoo
Town Centre Securities (LON:TOWN) shareholders have earned a 12% CAGR over the last five years
Stock pickers are generally looking for stocks that will outperform the broader market. Buying under-rated businesses is one path to excess returns. For example, long term Town Centre Securities Plc (LON:TOWN) shareholders have enjoyed a 45% share price rise over the last half decade, well in excess of the market return of around 25% (not including dividends). However, more recent returns haven't been as impressive as that, with the stock returning just 1.1% in the last year, including dividends. Let's take a look at the underlying fundamentals over the longer term, and see if they've been consistent with shareholders returns. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS). Town Centre Securities has made a profit in the past. On the other hand, it reported a trailing twelve months loss, suggesting it isn't reliably profitable. So it might be better to look at other metrics to try to understand the share price. On the other hand, Town Centre Securities' revenue is growing nicely, at a compound rate of 3.2% over the last five years. It's quite possible that management are prioritizing revenue growth over EPS growth at the moment. You can see how earnings and revenue have changed over time in the image below (click on the chart to see the exact values). We consider it positive that insiders have made significant purchases in the last year. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. This free report showing analyst forecasts should help you form a view on Town Centre Securities As well as measuring the share price return, investors should also consider the total shareholder return (TSR). Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Town Centre Securities, it has a TSR of 74% for the last 5 years. That exceeds its share price return that we previously mentioned. And there's no prize for guessing that the dividend payments largely explain the divergence! Town Centre Securities shareholders are up 1.1% for the year (even including dividends). But that was short of the market average. On the bright side, the longer term returns (running at about 12% a year, over half a decade) look better. It's quite possible the business continues to execute with prowess, even as the share price gains are slowing. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. For instance, we've identified 4 warning signs for Town Centre Securities (1 is significant) that you should be aware of. Town Centre Securities is not the only stock that insiders are buying. For those who like to find lesser know companies this free list of growing companies with recent insider purchasing, could be just the ticket. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on British exchanges. — Investing narratives with Fair Values Vita Life Sciences Set for a 12.72% Revenue Growth While Tackling Operational Challenges By Robbo – Community Contributor Fair Value Estimated: A$2.42 · 0.1% Overvalued Vossloh rides a €500 billion wave to boost growth and earnings in the next decade By Chris1 – Community Contributor Fair Value Estimated: €78.41 · 0.1% Overvalued Intuitive Surgical Will Transform Healthcare with 12% Revenue Growth By Unike – Community Contributor Fair Value Estimated: $325.55 · 0.6% Undervalued View more featured narratives — Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Yahoo
an hour ago
- Yahoo
UK backs quantum with £500m
The UK government will pump over £500m into quantum computing and related technologies – a major show of confidence in a sector seen as critical to the future of the UK economy and its national security. The investment forms part of Labour's broader industrial strategy and follows April's £121m pledge on 'world quantum day'. The new funding package aims to boost R&D, scale advanced quantum infrastructure, and accelerate commercialisation of applications like healthcare or defence. 'Backing our world-class quantum researchers and businesses is an important part of our plan for change', said tech secretary Peter Kyle. The UK is betting big on quantum to not only stimulate high-skilled jobs and private investment, but also to help shore up technological sovereignty in a fast moving global race dominated by the US and increasingly, China. The announcement comes just weeks after British quantum companies Oxford lonics and the quantum division of Oxford Instruments were acquired by American buyers – deals that have reignited fears about the UK's ability to retain control over strategic tech assets. 'Making sovereign quantum computing capacity is important for both national security and economic resilience', claimed Gerald Mullally, interim chief executive at Quantum Oxford Circuits. Some have said that the new funding is also set to prevent such sell-offs, signalling long-term government backing for homegrown scale-ups. 'The global race for quantum computing is reaching prime time', said Richard Murray, chief executive of Orca Computing. 'Several other countries are putting in sizeable commitments – if we're not, we risk losing our head'. Quantum tech can perform calculations far beyond the reach of a classic compute, making it applicable to real-time optimisation of energy grids, drugs discovery or early dementia diagnosis. It has already been tested to improve the tracking of the London underground, and government advisers have said it could save the economy millions, while transforming public services. Yet, quantum remains largely unregulated – unlike AI, which has seen intensifying policy attention in the UK and EU. But as capabilities scale, officials are expected to explore governance and safeguards for national security. Quantum has been placed at the forefront of the government's ambition to level up regional innovation clusters, with the UK boasting the second-largest quantum startup ecosystem globally, behind just the US, with hubs in Oxford, Bristol and Glasgow. The department of science, innovation and technology claimed these hubs were critical to translating 'deep science into deep growth'. 'Quantum is much more of a game changer for humanity as AI or the internet', claimed Tom Grinyer, chief executive of the Institute of Physics. 'We cannot let our advantage slip'. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
